ArticleFrontiers in physiology2025
Clinical validation of comprehensive time- and frequency-domain photoplethysmography features from a single-sensor system for non-invasive assessment of vascular load and systolic blood pressure.
Article in Frontiers in physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Interpretable photoplethysmography-based machine-learning model for noninvasive assessment of systolic blood pressure.Frontiers in physiology · 2026Article
- Radial pulse harmonic analysis for cardiometabolic assessment: a computational and translational mini review.Frontiers in endocrinology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Hypertension remains a silent yet powerful driver of cardiovascular disease-one of the world's leading causes of death. Despite being treatable, it often goes undetected until complications arise. Photoplethysmography (PPG), a low-cost, non-invasive tool, holds promise for identifying vascular changes linked to high blood pressure. However, current single-site methods primarily focus on time-domain signals, often missing rich spectral data that could enhance early detection of hypertensive changes. Methods: We designed a compact, noise-resistant PPG acquisition system (Taiwan Patent No. 114206342) aimed at real-world usability and recruited 590 adults from cardiology outpatient clinics. Using a validated oscillometric device, systolic blood pressure (SBP) was measured and categorized into four groups (≤120, 121-139, 140-159, ≥160 mmHg). Ninety-second fingertip PPG recordings (500 Hz) underwent careful pre-processing-filtering, normalization, and artifact rejection. We extracted 19 features covering waveform shape, sharpness, heart rate variability (HRV), and frequency-domain harmonic ratios. Group differences were assessed using ANOVA or Kruskal-Wallis tests, with Results: Several features demonstrated strong associations with SBP levels. Waveform sharpness indices (1_10, 1_8, 1_6, 1_5, 1_3, 1_2) and harmonic ratios (H2/H1, H3/H1, H4/H1) showed a progressive decline as SBP increased-signaling a loss of higher-frequency components likely due to vascular stiffening. Time-domain features revealed that individuals with elevated SBP had prolonged systolic phases, shorter diastolic intervals, and higher Ts/Td ratios. Peak amplitudes (P1, P2), systolic and diastolic slopes, and overall waveform area also differed significantly by group. Effect sizes ranged from small to moderate, with the most pronounced changes seen in waveform sharpness. Conclusion: Our results demonstrate the promise of a single-sensor PPG-based approach for monitoring hypertension-related, subtle vascular alterations by combining morphological and spectral information. Progressive decline in harmonic ratios provides new information on arterial stiffening and changed wave reflections. This level of physiological depth combined with a remarkably simple and portable approach is the key that could allow wearable devices to provide immediate blood pressure screening for unprecedented widespread user engagement. These aspects are facilitated by making the test easier to operate than standard PCR and combining it with types of analyte detection that expand its performance capabilities in this specific disease context.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.